PRISM BioLab, a biotechnology firm, is proposing little particle inhibitors of protein-protein interaction (PPI) targets, declared that it has gone into an objective selective exploration and licensing agreement with ONO PHARMACEUTICAL CO...
.jpg "Sightsavers India Fellowship Program Invites Applications for Promising Ophthalmologists")
Sightsavers India, a development organisation dedicated to eliminating avoidable blindness and promoting equality of opportunity for individuals with disabilities, announces the commencement of applications for its annual Fellowship Programme
.jpg "India's pharma Exports Increase 10% to USD 27.9 Billion in FY24")
The nation's drug and pharmaceutical exports rose 9.67 percent year-on-year to USD 27.9 billion in 2023-24, even though total exports decreased by 3% in the previous fiscal year. Pharma exports increased by 12.73 percent to USD 2.8 billion in...
The recent Mumbai edition of analytica Anacon India and India Lab Expo, organised jointly by Messe Muenchen India and the Indian Analytical Instruments Association (IAIA), concluded successfully with satisfied exhibitors and delighted visitors.
Lupin Limited, a leading global pharmaceutical company, has secured the Establishment Inspection Report (EIR) from the US Food and Administration (FDA) for its Aurangabad manufacturing facility. The investigation was led from March 6 to March 15...
.jpg "Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality")
Sarvodaya Hospital, a leading multidisciplinary tertiary care facility in Greater Noida West, witnessed a groundbreaking advancement in orthopedic surgery as a 70-year-old male underwent a transformative Total Knee Replacement (TKR)
Pfizer Inc., a biopharmaceutical firm, reported that Emblaveo (aztreonam-avibactam) has received marketing approval from the European Commission (EC) for the treatment of adult patients with pyelonephritis, hospital-acquired pneumonia (HAP)...
Ipsen, a worldwide biopharmaceutical organization, announced a worldwide collaboration with Skyhawk Therapeutics, a clinical-stage biopharmaceutical organization, to find and foster novel little particles that tweak RNA for intriguing neurological...
In a deal worth up to $380 million in upfront and milestone payments, Bristol Myers Squibb and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing...
Light Pharma Inc, a biotechnology company creating designated and extraordinary cancer treatments utilizing its restrictive RADR® artificial intelligence and AI ("ML") stage with various clinical-stage drug programs, reported today that the...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
